We are monitoring the impact of COVID-19 & Recession alarm on MEA Spine Biologics Market Get in touch with us for detailed analysis Know More

Know More

Share on

Middle East & Africa Spine Biologics Market Research Report - Segmented By Product Type, Surgery Type & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 4123
Pages: 130

Middle East & Africa Spine Biologics Market Size & Growth (2022 to 2027)

As per the research report, the Middle East and Africa Spine Biologics Market Size is valued at USD 146.30 million in 2022 and is expected to grow at a CAGR of 4.5%, reaching 182.32 million by 2027 during the forecast period 2022 to 2027.

Another key factor is that there was a massive demand for spine biologics during the pandemic, which may fuel market expansion. The National Research Council and Biologics, for example, partnered on vaccine clinical development in UAE.

Another essential factor to consider is that the market is primarily driven by increasing capital investment from key market participants, an increase in the burden of chronic diseases, the loss of patent protection for top biologic medications, and rising demand and acceptance for novel therapies.

According to the World Health Organization, chronic diseases kill more than 41 million people in MEA annually. The most common chronic disease is cardiovascular disease, which kills 5 million people per year, followed by cancer (6 million), respiratory disorders (1.9 million), and diabetes (1.6 million).

The Spine biologics market will eventually profit from factors such as the need to develop MEA healthcare and the efforts of government agencies and international organizations to encourage and accelerate growth. These government and private sector efforts to promote healthcare will significantly boost the market in the future.

The healthcare system is urgently rearranging cancer services to guarantee that patients continue to receive necessary care while avoiding SARS-CoV-2 infection. This has had a little negative impact, but the situation is expected to normalize after the epidemic.

However, several prescription medications have adverse effects, and the cost of treatment is substantial, making it unaffordable for the less fortunate in rural places.

This research report on the MEA Spine Biologics Market has been segmented and sub-segmented into the following categories.

By Product Type:

  • platelet Rich Plasma
  • Bone Graft
  • Bone Graft Substitutes
  • Bone Marrow Aspirate Therapy

By Surgery Type:

  • Transforaminal Lumbar Interbody Fusion
  • Anterior Lumbar Interbody Fusion
  • Lateral Lumbar Interbody Fusion
  • Anterior Cervical Discectomy And Fusion
  • Posterior Lumbar Interbody Fusion
  • Others

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East and Africa spine biologics market hold a moderate share globally, and the trend is expected to continue.

The UAE spine biologics market is expected to reach a decent CAGR due to the increased prevalence of chronic diseases, well-established pharmaceutical corporations, and growth in the number of biotech companies are the key factors influencing the market. In addition, market participants are also spending on research and development operations to produce novel biologic therapies for cancer treatment.

Regionally the most recent market trends are investigated, offering vital information on the present market scenario. The critical factor is an increased investment, which has contributed to the market's overall expansion. For example, Novartis AG committed around USD 300 million to a biologics facility in the UAE and a large-scale biologics plant in Ireland, which were scheduled to be finished by 2022.

The Saudi Arabia Spine Biologics Market in this area is predicted to be fueled by well-established infrastructure, sustained economic growth, and rising healthcare spending.

KEY MARKET PLAYERS

The leading companies dominating the MEA Spine Biologics Market profiled in the report are Globus Medical, Inc., Medtronic plc, Orthofix International N.V., RTI Surgical, Inc., SeaSpine, Zimmer Biomet Holdings, Inc, NuVasive, Inc., Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., 

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods     

                1.4 General Study Assumptions  

2. Research Methodology       

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Surgery type                                                              

                                5.1.1 Introduction                                           

                                5.1.2 Anterior Cervical Discectomy and Fusion                                   

                                5.1.3 Posterior Lumbar Interbody Fusion                                              

                                5.1.4 Transforaminal Lumbar Interbody Fusion                                  

                                5.1.5 Anterior Lumbar Interbody Fusion                               

                                5.1.6 Lateral Lumbar Interbody Fusion                                   

                                5.1.7 Others                                      

                                5.1.8  Y-o-Y Growth Analysis, By surgery type                                     

                                5.1.9  Market Attractiveness Analysis, By surgery type                                   

                                5.1.10 Market Share Analysis, By surgery type                                   

                5.2 Product type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Bone graft                                               

                                                5.2.2.1 Autograft                             

                                                5.2.2.2 Allograft               

                                5.2.3 Bone graft substitutes                                       

                                                5.2.3.1 Synthetic bone grafts                     

                                                5.2.3.2 Demineralized bone matrix                          

                                                5.2.3.3 Bone Morphogenetic proteins                   

                                5.2.4 Platelet rich plasma                                             

                                5.2.5 Bone marrow aspitaye therapy                                      

                                5.2.6 Y-o-Y Growth Analysis, By Product type                                     

                                5.2.7 Market Attractiveness Analysis, By Product type                                   

                                5.2.8 Market Share Analysis, By Product type                                     

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Surgery type                 

                                                6.1.3.3 By Product Type                

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Surgery type                 

                                                6.1.4.3 By Product Type                

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Surgery type                 

                                                6.1.5.3 By Product Type                

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1  Alphatec Holdings Inc.                                                          

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Depuy Synthes                                                         

                8.3 Exactech Inc.                                                              

                8.4 Globus Medical Inc.                                                

                8.5 Medtronic plc.                                                           

                8.6 NuVasive Inc.                                                            

                8.7 Orthofix International N.V.                                                  

                8.8 RTI Surgical Inc.                                                         

                8.9 SeaSpine                                                     

                8.10 Zimmer Biomet Holdings Inc.                                                            

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  1. Middle East and Africa Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  2. Middle East and Africa Anterior Cervical Discectomy and Fusion Market By Region, From 2022 to 2027 ( USD Million )
  3. Middle East and Africa Posterior Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  4. Middle East and Africa Transforaminal Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  5. Middle East and Africa Anterior Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  6. Middle East and Africa Lateral Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  7. Middle East and Africa Others Market By Region, From 2022 to 2027 ( USD Million )
  8. Middle East and Africa Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  9. Middle East and Africa Bone graft Market By Region, From 2022 to 2027 ( USD Million )
  10. Middle East and Africa Bone graft substitutes Market By Region, From 2022 to 2027 ( USD Million )
  11. Middle East and Africa Platelet rich plasma Market By Region, From 2022 to 2027 ( USD Million )
  12. Middle East and Africa Bone marrow aspirate therapy Market By Region, From 2022 to 2027 ( USD Million )
  13. Middle East Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  14. Middle East Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  15. Africa Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  16. Africa Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  17. Middle East and Africa Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )
  18. Middle East and Africa Allograft Market By Region, From 2022 to 2027 ( USD Million )
  19. Middle East and Africa Autograft Market By Region, From 2022 to 2027 ( USD Million )
  20. Middle East Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )
  21. Africa Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample